These results suggest that these abnormalities may emerge with age and most certainly under the influence of other AD risk factors, promoting APP endocytosis and its subsequent cleavage by endosomal BACE-1, which initiates the amyloid cascade. The gene discussed is APP; the disease is Alzheimer disease.